July 9, 2019
BioMarin to Submit Hemophilia A Gene Therapy to U.S. and European Regulators in Q4
Read More
April 2, 2019
Sangamo Provides Positive Updates on Hemophilia A and Beta Thalassemia Gene Therapy Trials
Read More
X